Apogenix raises 7.5M euros; Cornerstone buys Cardiokine; Xoma nabs $10M loan;

@FierceBiotech: Bleak forecast puts Lilly's R&D game plan to the test. Will this change Lechleiter's approach? Article | Follow @FierceBiotech

@JohnCFierce: Germany's Apogenix raises €7.5M for glioblastoma drug work. Release | Follow @JohnCFierce

@RyanMFierce: Here's my own take on @Quintiles new digital patient unit, with insights from the group's chief: Story | Follow @RyanMFierce

@FierceMedDev: FDA orders safety evaluation of vaginal mesh--Bloomberg. Article | Follow @FierceMedDev

> Germany's Apogenix GmbH has banked a 7.5 million euro round led by dievini Hopp BioTech holding GmbH. The biotech is working on a new treatment for glioblastoma. Release

> Cornerstone Therapeutics has struck a deal to buy Cardiokine for a modest down payment of $1 million and up to $147 million based on the future success of the biotech's heart drugs. News

> Xoma ($XOMA) has lined up a $10 million loan from GE Capital to help fund clinical trials of its lead drug. Story

> Abbott Biotech Ventures has made an unspecified investment in NeuroGenetic Pharmaceuticals, which is working on Alzheimer's. Release

Pharma News

@FiercePharma: Pennsylvania appeals court affirms $45M in Prempro damages; Pfizer says it'll go to state supreme court. Report | Follow @FiercePharma

> Pfizer gains ground in India, but Abbott still rules. Article

> Lilly surprises with lower-than-expected 2012 forecast. News

> FDA restricts some antibiotics in livestock. Item

Vaccine News

> Study: Most girls who get HPV vax say they see need to practice safe sex. Item

> FDA approves Pfizer's Prevnar 13 for adults over 50. Article

> Vaccine combo shows early promise against AIDS. Story

> Preclinical data in hand, Tetragenetics seeks partners for vaccine platform. Report

> GSK's genital herpes vaccine gets disappointing results. Article

> Argentina fines GSK $93K for Synflorix vaccine trial. News

Manufacturing News

> Novartis adds OTC drug plant to GMP fix list. News

> AZ starts work on record-setting plant in China. Item

> Report: Big Pharma finds Indian collaborations costly. Story

> Pharma fires, pollution targeted in India. More

> Hospira enters angry-investor phase of remediation. Article

> Expired-drug take vs. toss debate gets new vetting. Story

And Finally... After gaining encouraging primate data for an experimental AIDS vaccine developed by J&J ($JNJ) and the U.S. military, investigators say they're ready to start testing it in human studies. Report

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.